Literature DB >> 596243

Digitalis therapy in a 70-year-old population.

S Landahl, B Lindblad, S Roupe, B Steen, A Svanborg.   

Abstract

In the population study "70-year-old people in Gothenburg" 14% of the probands were found to be undergoing treatment with digitalis, 6% with digoxin, 6% with digitoxin and 2% with other glycosides. A comparison between results of the interview method and those of S-digoxin analyses indicates that the interview method was acceptable. As far as can be judged from S-digoxin analyses, only about 60% of the treated patients were on a dosage considered to be effective and free from obvious risks of side-effects. Out of the 130 70-year-olds who were on digitalis treatment, 37% had obvious symptoms of heart disease requiring such treatment, 34% lacked symptoms of arrhythmia and/or congestive failure but had heart volumes larger than those used as reference values in younger age groups, and 29% had no symptoms indicating digitalis treatment. At least 13% of the population had indications for digitalis therapy and about 75% of those apparently needing digitalis were on such treatment. Thus both over- and underdiagnosis of heart disease requiring digitalis therapy were common in this age group.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 596243     DOI: 10.1111/j.0954-6820.1977.tb16861.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  3 in total

Review 1.  Digoxin toxicity in the aged. Characterising and avoiding the problem.

Authors:  A P Passmore; G D Johnston
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

2.  Digoxin dosage in renal insufficiency: impracticality of basing it on the creatinine clearance, body weight and volume of distribution.

Authors:  F Keller; M Molzahn; R Ingerowski
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

3.  Serum digoxin concentrations in a representative digoxin-consuming adult population.

Authors:  O Impivaara; E Iisalo
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.